Reimagining Medicine slide image

Reimagining Medicine

Company overview Innovation: Pipeline overview Appendix Financial review 2023 priorities Appendix Abbreviations Innovation: Clinical trials 49 Investor Relations | Q4 2022 Results NOVARTIS | Reimagining Medicine
View entire presentation